Drug Shortage Report for KADIAN

Last updated on 2018-05-10 History
Report ID 20588
Drug Identification Number 02184435
Brand name KADIAN
Common or Proper name Morphine ER
Company Name BGP PHARMA ULC
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 20MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-04-06
Actual start date 2018-04-06
Estimated end date 2018-05-09
Actual end date 2018-05-09
Shortage status Resolved
Updated date 2018-05-10
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2018-05-10 English Compare
v33 2018-05-09 French Compare
v32 2018-05-09 English Compare
v31 2018-05-07 French Compare
v30 2018-05-07 English Compare
v29 2018-04-07 English Compare
v28 2018-04-06 French Compare
v27 2018-04-06 English Compare
v26 2018-04-05 French Compare
v25 2018-04-05 English Compare
v24 2018-04-02 French Compare
v23 2018-04-02 English Compare
v22 2018-03-29 French Compare
v21 2018-03-29 English Compare
v20 2018-03-26 French Compare
v19 2018-03-26 English Compare
v18 2018-03-23 French Compare
v17 2018-03-23 English Compare
v16 2018-03-21 French Compare
v15 2018-03-21 English Compare

Showing 1 to 20 of 34